Clinical assessment incorporating a personal genome

[1]  R. Collins,et al.  Genetic variants associated with Lp(a) lipoprotein level and coronary disease. , 2009, The New England journal of medicine.

[2]  I. Tikhonova,et al.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.

[3]  Dmitry Pushkarev,et al.  Single-molecule sequencing of an individual human genome , 2009, Nature Biotechnology.

[4]  M. P. van den Berg,et al.  A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy , 2009, Human mutation.

[5]  J. O’Connell,et al.  Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. , 2009, JAMA.

[6]  Thomas D. Wu,et al.  A highly annotated whole-genome sequence of a Korean individual , 2009, Nature.

[7]  M. Marra,et al.  Massively parallel sequencing: the next big thing in genetic medicine. , 2009, American journal of human genetics.

[8]  Bjarni V. Halldórsson,et al.  Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. , 2009, Arthritis and rheumatism.

[9]  J. Corral,et al.  Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy. , 2009, Blood.

[10]  E. Antman,et al.  Cytochrome p-450 polymorphisms and response to clopidogrel. , 2009, The New England journal of medicine.

[11]  Daniel I Chasman,et al.  Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. , 2009, Atherosclerosis.

[12]  T. Eschenhagen,et al.  Impact of the CYP2D6 Genotype on the Clinical Effects of Metoprolol: A Prospective Longitudinal Study , 2009, Clinical pharmacology and therapeutics.

[13]  R. Altman,et al.  Estimation of the warfarin dose with clinical and pharmacogenetic data. , 2009, The New England journal of medicine.

[14]  Daniel E. Weeks,et al.  Interpretation of Genetic Association Studies: Markers with Replicated Highly Significant Odds Ratios May Be Poor Classifiers , 2009, PLoS genetics.

[15]  P. Stenson,et al.  The Human Gene Mutation Database: 2008 update , 2009, Genome Medicine.

[16]  Y. Gong,et al.  β‐Adrenergic Receptor Gene Polymorphisms and β‐Blocker Treatment Outcomes in Hypertension , 2008, Clinical pharmacology and therapeutics.

[17]  The UniProt Consortium,et al.  The Universal Protein Resource (UniProt) 2009 , 2008, Nucleic Acids Res..

[18]  B. Nordestgaard,et al.  Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease. , 2008, The Journal of clinical endocrinology and metabolism.

[19]  P. Giral,et al.  Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. , 2008, Pharmacogenomics.

[20]  D. Altshuler,et al.  Extension of Type 2 Diabetes Genome-Wide Association Scan Results in the Diabetes Prevention Program , 2008, Diabetes.

[21]  R. Collins,et al.  SLCO1B1 variants and statin-induced myopathy--a genomewide study. , 2008, The New England journal of medicine.

[22]  S. Kathiresan,et al.  Polymorphisms Associated With Cholesterol and Risk of Cardiovascular Events , 2008 .

[23]  J. Lupski,et al.  The complete genome of an individual by massively parallel DNA sequencing , 2008, Nature.

[24]  Y. Turpaz,et al.  CYP4F2 genetic variant alters required warfarin dose. , 2008, Blood.

[25]  Sean Connors,et al.  Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.

[26]  Timothy B. Stockwell,et al.  The Diploid Genome Sequence of an Individual Human , 2007, PLoS biology.

[27]  E. Topol,et al.  A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[29]  M. Niemi,et al.  Influence of Drug Transporter Polymorphisms on Pravastatin Pharmacokinetics in Humans , 2007, Pharmaceutical Research.

[30]  Jing Chen,et al.  PolyDoms: a whole genome database for the identification of non-synonymous coding SNPs with the potential to impact disease , 2006, Nucleic Acids Res..

[31]  Emidio Capriotti,et al.  Bioinformatics Original Paper Predicting the Insurgence of Human Genetic Diseases Associated to Single Point Protein Mutations with Support Vector Machines and Evolutionary Information , 2022 .

[32]  Hugh Calkins,et al.  Desmosomal Dysfunction due to Mutations in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2006, Circulation research.

[33]  J. Spertus,et al.  β2-Adrenergic Receptor Genotype and Survival AmongPatients Receiving β-Blocker Therapy After an Acute Coronary Syndrome , 2005 .

[34]  M. Charng,et al.  A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. , 2005, Human molecular genetics.

[35]  Nobuo Sasaki,et al.  Insertion/deletion polymorphism in the BRCA2 nuclear localization signal. , 2005, Biomedical research.

[36]  A. Tajik,et al.  Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.

[37]  P. Byers,et al.  Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. , 2004, American journal of human genetics.

[38]  Noriyuki Fuku,et al.  Mitochondrial Genome Single Nucleotide Polymorphisms and Their Phenotypes in the Japanese , 2004, Annals of the New York Academy of Sciences.

[39]  W. Sly,et al.  Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Carpten,et al.  Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. , 2003, The New England journal of medicine.

[41]  U. Hellman,et al.  Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. , 2003, Journal of molecular and cellular cardiology.

[42]  G. Jennings,et al.  Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. , 2003, Pharmacogenetics.

[43]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[44]  I. Zineh,et al.  β1‐Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol , 2003, Clinical pharmacology and therapeutics.

[45]  Yuichi Sugiyama,et al.  Polymorphisms of OATP‐C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics , 2003, Clinical pharmacology and therapeutics.

[46]  P. Bork,et al.  Human non-synonymous SNPs: server and survey. , 2002, Nucleic acids research.

[47]  C. Stanley,et al.  Mutations in BTD causing biotinidase deficiency , 2001, Human mutation.

[48]  H Niimura,et al.  Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. , 2001, Journal of the American College of Cardiology.

[49]  A. Superti-Furga,et al.  Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance , 2001, Human mutation.

[50]  R. Burgeson,et al.  A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. , 1994, Genomics.

[51]  X. Estivill,et al.  Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine , 1994, Nature Genetics.

[52]  P. Marynen,et al.  Association between XV2c/CS7/KM19/D9 haplotypes and the ΔF508 mutation A study of 57 Belgian families , 1990, Human Genetics.

[53]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[54]  J. Stockman.  Iron-Overload–Related Disease in HFE Hereditary Hemochromatosis , 2009 .

[55]  J. Spertus,et al.  Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. , 2005, JAMA.

[56]  S. Grundy,et al.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[57]  Joshua M. Stuart,et al.  Integrating genotype and phenotype information: an overview of the PharmGKB project , 2001, The Pharmacogenomics Journal.